GlassScriptPhysician profile
Jerome Marc Kane
NPI 1558364232
$24,240.71
in general payments reported to CMS, 2019-2025
87 companies · $3,650 in 2025
The $3,650 reported for 2025 was more than what 81% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,250 · 2020: $2,744 · 2021: $2,768 · 2022: $2,999 · 2023: $4,392 · 2024: $3,438 · 2025: $3,650.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Education: $298.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,181.19 |
| Education | $297.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,690.58 | 2019-2025 | |
| Teva Pharmaceuticals USA, INC. | $2,627.46 | 2019-2025 | Ajovy, Austedo Xr, Austedo |
| Novartis Pharmaceuticals Corporation | $1,351.45 | 2019-2025 | |
| Allergan, INC. | $1,246.21 | 2019-2022 | |
| Pfizer INC. | $819.93 | 2019-2025 | |
| Lilly USA, LLC | $739.59 | 2019-2025 | Kisunla, Amyvid, Emgality |
| Acadia Pharmaceuticals INC | $698.24 | 2019-2025 | Nuplazid |
| Biogen, INC. | $659.59 | 2019-2025 | Vumerity, Skyclarys, Tysabri |
| Ucb, INC. | $658.04 | 2019-2025 | Rystiggo, Briviact |
| Neurocrine Biosciences, INC. | $512.60 | 2019-2025 | Ingrezza, Ongentys |
| Merz Pharmaceuticals, LLC | $493.67 | 2021-2024 | Xeomin |
| Sk Life Science, INC. | $428.67 | 2021-2025 | Xcopri |
| Alnylam Pharmaceuticals INC. | $425.75 | 2020-2024 | Onpattro, Amvuttra |
| Jazz Pharmaceuticals INC. | $404.82 | 2019-2024 | |
| Biohaven Pharmaceuticals, INC. | $401.92 | 2020-2021 |
Show all 87 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $372.39 | 2021-2025 | |
| Celgene Corporation | $364.81 | 2021-2023 | Zeposia |
| Genzyme Corporation | $360.46 | 2019-2023 | |
| Lundbeck LLC | $337.86 | 2019-2025 | Vyepti, Rexulti |
| Grifols USA, LLC | $333.14 | 2020-2025 | Gamunex-C |
| Emd Serono, INC. | $331.81 | 2019-2025 | Mavenclad |
| Amgen INC. | $320.11 | 2019-2025 | Uplizna |
| Acorda Therapeutics, INC | $279.84 | 2019-2021 | |
| Impel Pharmaceuticals INC. | $278.55 | 2022-2023 | Trudhesa |
| Alexion Pharmaceuticals, INC. | $256.88 | 2021-2025 | Ultomiris, Soliris |
| Harmony Biosciences LLC | $248.89 | 2020-2024 | Wakix |
| Adamas Pharmaceuticals, INC. | $246.45 | 2019-2020 | |
| Horizon Therapeutics Plc | $244.61 | 2021-2023 | Uplizna |
| Ge Healthcare | $236.10 | 2020-2025 | |
| Argenx US, INC. | $227.34 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Janssen Pharmaceuticals, INC | $217.85 | 2020-2022 | |
| Axsome Therapeutics, INC. | $197.25 | 2023-2024 | Sunosi |
| Genentech USA, INC. | $187.28 | 2019-2023 | Ocrevus |
| Vanda Pharmaceuticals INC. | $186.75 | 2025 | Ponvory |
| Sunovion Pharmaceuticals INC. | $176.35 | 2019-2021 | |
| Scilex Pharmaceuticals INC. | $171.78 | 2022-2024 | Ztlido |
| Upsher-Smith Laboratories LLC | $156.99 | 2020-2023 | |
| Octapharma USA, INC. | $153.05 | 2022-2024 | Octagam Immune Globulin (Human), Panzyga |
| Mdd US Operations, LLC | $152.27 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $151.98 | 2021-2025 | Wainua |
| Livanova USA, INC. | $150.25 | 2019-2024 | Vns Therapy Sentiva Model 1000 Generator |
| Janssen Biotech, INC. | $149.32 | 2025 | Tremfya |
| Avadel Cns Pharmaceuticals, LLC | $147.69 | 2023-2025 | Lumryz |
| Penumbra, INC. | $146.87 | 2022 | |
| Ipsen Biopharmaceuticals, INC | $129.42 | 2021-2025 | Dysport |
| Tg Therapeutics, INC. | $125.39 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $118.99 | 2020 | |
| Boston Scientific Corporation | $117.72 | 2019-2025 | Wavewriter Alpha Prime 16 |
| Supernus Pharmaceuticals, INC. | $114.62 | 2019-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $114.25 | 2022-2025 | Hyqvia |
| Otsuka America Pharmaceutical, INC. | $113.38 | 2024 | Rexulti, Nuedexta |
| Csl Behring | $111.00 | 2019-2024 | Hizentra |
| Corium, LLC | $109.20 | 2022 | |
| Amneal Pharmaceuticals LLC | $98.49 | 2019-2025 | Crexont, Rytary |
| Biohaven Pharmaceutical Holding Company LTD. | $96.92 | 2022 | |
| Amylyx Pharmaceuticals, INC. | $88.12 | 2023 | Relyvrio |
| Tanabe Pharma America, INC. | $77.82 | 2021-2022 | |
| Akcea Therapeutics, INC. | $69.56 | 2019-2020 | |
| Grt US Holding, INC. | $63.00 | 2019 | |
| Banner Life Sciences, LLC | $61.54 | 2021-2022 | |
| Vertiflex, INC. | $57.15 | 2019 | |
| Avion Pharmaceuticals | $53.18 | 2022 | |
| Springworks Therapeutics, INC. | $44.91 | 2025 | Gomekli |
| Tersera Therapeutics LLC | $43.26 | 2025 | Quzyttir |
| Currax Pharmaceuticals LLC | $42.37 | 2020-2021 | |
| C2n Diagnostics, LLC | $40.68 | 2025 | Precivityad2 |
| Avanos Medical | $35.71 | 2019 | |
| Mallinckrodt Enterprises LLC | $29.06 | 2019 | |
| Assertio Therapeutics, INC. | $28.69 | 2020 | |
| Averitas Pharma INC. | $27.72 | 2023 | Qutenza |
| Merz North America, INC. | $24.18 | 2020 | |
| Kyowa Kirin, INC. | $23.32 | 2022 | |
| Ani Pharmaceuticals, INC. | $19.59 | 2022 | |
| Silk Road Medical, INC. | $19.31 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Ns Pharma, INC. | $19.08 | 2023 | Viltepso |
| Abbott Laboratories | $17.80 | 2025 | Jot Dx |
| Almatica Pharma LLC | $17.44 | 2021 | |
| Catalyst Pharmaceuticals, INC. | $17.32 | 2023 | Firdapse |
| Mallinckrodt Hospital Products INC. | $16.01 | 2020 | |
| Sumitomo Pharma America, INC. | $15.52 | 2023 | Aptiom |
| Vertical Pharmaceuticals, LLC | $15.29 | 2019 | |
| Tonix Medicines, INC. | $15.05 | 2025 | Zembrace Symtouch |
| Azurity Pharmaceuticals, INC. | $14.18 | 2025 | Horizant |
| Nevro Corp. | $13.71 | 2023 | Senza |
| Aquestive Therapeutics, INC. | $13.15 | 2020 | |
| Xeris Pharmaceuticals, INC. | $12.24 | 2022 | |
| Strongbridge US INC. | $11.93 | 2020 |
Drugs and devices associated with these payments
Botox $1,864Qulipta $849Kesimpta $507Ubrelvy $503Nurtec Odt $459Leqembi $354Ingrezza $344Nuplazid $305Gamunex-C $284Vyepti $255Octagam Immune Globulin (Human) $254Panzyga $225Uplizna $224Austedo Xr $223Xeomin $220Sunosi $197Ponvory $187Ajovy $168Xywav $155Onpattro $155Trudhesa $150Rexulti $149Lumryz $148Vyvgart Hytrulo $145Kisunla $144Zeposia $143Wainua $139Ztlido $135Rystiggo $134Austedo $131Ultomiris $129Briumvi $125Xcopri $123Zavzpret $120Duopa $117Briviact $112Amyvid $112Amvuttra $111Vns Therapy Sentiva Model 1000 Generator $108Emgality $94.96Relyvrio $88.12Wakix $75.19Hyqvia $68.41Dysport $63.86Skyclarys $60.22Soliris $56.83Vyvgart $53.80Ongentys $53.10Hizentra $51.34Vumerity $48.36Vyalev $45.99Gomekli $44.91Ocrevus $43.29Quzyttir $43.26Precivityad2 $40.68Enroute Transcarotid Neuroprotection System $38.62Crexont $36.45Tysabri $34.42Mavenclad $32.04Zembrace Symtouch $30.88Tremfya $30.88Qutenza $27.72Reyvow $25.25Aubagio $24.07Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter $19.31Enroute Transcarotid Stent $19.31Viltepso $19.08Rytary $18.48Zepbound $18.15Jot Dx $17.80Firdapse $17.32Tosymra $15.83Nuedexta $15.71Aptiom $15.52Wavewriter Alpha Prime 16 $15.32Horizant $14.18Plegridy $13.94Senza $13.71
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerome Kane listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.